Hartree Partners reports 11.8% stake in Hudson Technologies
Hudson Technologies Inc. Schedule 13G/A amendment reports that Hartree Partners beneficially owned 4,971,302 shares of Hudson Technologies common stock, representing 11.8% of the class as of 06/30/2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Hudson Technologies Inc. Schedule 13G/A amendment reports that Hartree Partners beneficially owned 4,971,302 shares of Hudson Technologies common stock, representing 11.8% of the class as of 06/30/2026. The filing shows Hartree holds sole voting and dispositive power over the same 4,971,302 shares.
Insights
Hartree Partners reports an 11.8% stake with full voting and dispositive authority.
Hartree Partners is disclosed as beneficial owner of 4,971,302 shares of Hudson Technologies common stock as of 06/30/2026. The filing attributes both sole voting power and sole dispositive power over those shares to Hartree.
Because this is a Schedule 13G/A amendment, it is a passive ownership disclosure rather than an active transaction; subsequent filings may show changes in intent or status.
Key Figures
Key Terms
Schedule 13G/A regulatory
Beneficially owned financial
Sole dispositive power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Hartree Partners report in HDSN?
What form was filed to disclose Hartree's holdings in HDSN?
Is this Schedule 13G/A an indication of active trading by Hartree in HDSN?
AI-generated analysis. How Rhea-AI works. Not financial advice.